< Dirk F Moore Ph.D. » EOHSI Directory - EOHSI

Dirk F Moore , Ph.D.

Associate Professor Rutgers University, School of Public HealthEOHSI – Environmental and Population Health Bio-Sciences
Photo of Dirk F Moore Ph.D.


Recent Publications

  1. Cararo Lopes, E, Sawant, A, Moore, D, Ke, H, Shi, F, Laddha, S, Chen, Y, Sharma, A, Naumann, J, Guo, JY et al.. Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer. Clin Transl Med. 2023;13 (6):e1298. doi: 10.1002/ctm2.1298. PubMed PMID:37317665 PubMed Central PMC10267429
  2. Yashar, C, Khan, AJ, Chen, P, Einck, J, Poppe, M, Li, L, Yehia, ZA, Vicini, FA, Moore, D, Arthur, D et al.. Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Interstitial Brachytherapy Is Safe: First Results From the Tri-fraction Radiation Therapy Used to Minimize Patient Hospital Trips (TRIUMPH-T) Trial. Pract Radiat Oncol. 2023;13 (4):314-320. doi: 10.1016/j.prro.2023.03.006. PubMed PMID:37140504
  3. Cararo-Lopes, E, Sawant, A, Moore, D, Ke, H, Shi, F, Laddha, S, Chen, Y, Sharma, A, Naumann, J, Guo, JY et al.. Integrated metabolic and genetic analysis reveals distinct features of primary differentiated thyroid cancer and its metastatic potential in humans. medRxiv. 2023; :. doi: 10.1101/2023.03.09.23287037. PubMed PMID:36945575 PubMed Central PMC10029066
  4. Gulhati, P, Schalck, A, Jiang, S, Shang, X, Wu, CJ, Hou, P, Ruiz, SH, Soto, LS, Parra, E, Ying, H et al.. Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer. Nat Cancer. 2023;4 (1):62-80. doi: 10.1038/s43018-022-00500-z. PubMed PMID:36585453 PubMed Central PMC9925045
  5. Fosko, NK, Gribkova, Y, Krupa, K, Bs, KJ, Moore, D, Chen, C, Potdevin, L, Kumar, S, Eladoumikdachi, F, Kowzun, MJ et al.. The Use of Intraoperative Ultrasound During Breast Conserving Surgery. Clin Breast Cancer. 2023;23 (1):54-59. doi: 10.1016/j.clbc.2022.10.003. PubMed PMID:36319507
  6. Moore, DF, Sleat, DE, Lobel, P. A Method to Estimate the Distribution of Proteins across Multiple Compartments Using Data from Quantitative Proteomics Subcellular Fractionation Experiments. J Proteome Res. 2022;21 (6):1371-1381. doi: 10.1021/acs.jproteome.1c00781. PubMed PMID:35522998
  7. Gazivoda, VP, Kangas-Dick, AW, Greenbaum, AA, Roshal, J, Chen, C, Moore, DF, Langan, RC, Kennedy, TJ, Minerowicz, C, Alexander, HR et al.. Expression of PD-L1 in Patients With Malignant Peritoneal Mesothelioma: A Pilot Study. J Surg Res. 2022;277 :131-137. doi: 10.1016/j.jss.2022.04.005. PubMed PMID:35489218
  8. Dansu, DK, Liang, J, Selcen, I, Zheng, H, Moore, DF, Casaccia, P. PRMT5 Interacting Partners and Substrates in Oligodendrocyte Lineage Cells. Front Cell Neurosci. 2022;16 :820226. doi: 10.3389/fncel.2022.820226. PubMed PMID:35370564 PubMed Central PMC8968030
  9. Deek, MP, Yegya-Raman, N, Daroui, P, Balasubramanian, S, Malhotra, J, Moore, D, Patel, M, Wang, SJ, Aisner, J, Jabbour, SK et al.. Overexpression of excision repair cross-complementing 1 gene associates with higher risk of therapeutic failure after definitive chemoradiation for unresectable non-small cell lung cancer. Ann Palliat Med. 2021;10 (7):7205-7213. doi: 10.21037/apm-21-182. PubMed PMID:34263627
  10. Greco, SH, August, DA, Shah, MM, Chen, C, Moore, DF, Masanam, M, Turner, AL, Jabbour, SK, Javidian, P, Grandhi, MS et al.. Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database. Surg Open Sci. 2021;3 :22-28. doi: 10.1016/j.sopen.2020.12.001. PubMed PMID:33490937 PubMed Central PMC7807160
Search PubMed
Connections Business Directory | Leaflet | © OpenStreetMap contributors

School of Public Health Room 215 Piscataway NJ 08854